Advanced

ADVENZYMES.NS

Tags: IN Basic Materials Chemicals - Specialty

Advanced Enzyme Technologies Limited Price (ADVENZYMES.NS)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

111,879,311

(0.0566)%

Market Cap of Advanced (ADVENZYMES.NS)

Market cap:

As of , ADVENZYMES.NS has a market cap of . This makes ADVENZYMES.NS the 777th most valuable company in the IN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Revenue and Profitability

Year	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Revenue	1,161,138,710	1,712,611,360	2,194,449,333	2,145,280,000	2,221,170,000	2,926,470,000	3,301,080,000	3,879,130,000	4,177,370,000	4,415,550,000	5,004,460,000	5,289,040,000	5,406,370,000	6,234,770,000
Net Income	166,721,511	337,546,721	498,188,398	197,370,000	509,800,000	758,490,000	906,490,000	900,550,000	1,110,590,000	1,292,940,000	1,459,310,000	1,195,820,000	1,056,390,000	1,333,050,000
FCF USD	-239,662,951	-1,098,822,753	98,871,119	459,730,000	411,250,000	879,290,000	955,240,000	1,050,220,000	1,161,800,000	902,490,000	1,433,120,000	941,150,000	1,021,810,000	940,560,000
OCF USD	11,757,678	905,461,070	411,237,287	555,670,000	537,310,000	977,510,000	1,073,540,000	1,159,750,000	1,285,660,000	1,409,000,000	1,628,920,000	1,222,910,000	1,403,620,000	1,413,690,000

Financial Health - DEBT

Year	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
YTPD	0.00	2.94	1.51	3.09	0.72	0.33	0.15	0.15	0.04	0.07	0.07	0.15	0.16	0.17
D/E	1.03	2.13	1.13	1.00	0.54	0.36	0.12	0.12	0.05	0.04	0.03	0.03	0.03	0.04
CA/CL	1.41	0.73	0.94	0.69	0.80	1.26	2.25	2.09	4.33	6.31	7.64	9.94	9.30	7.61
TA/TL	1.72	1.39	1.72	1.73	2.09	2.70	5.54	4.88	7.63	8.80	9.46	9.96	10.33	9.34
Total Debt	651,442,684	2,063,971,539	1,843,524,931	1,666,940,000	1,150,230,000	1,013,450,000	540,200,000	657,090,000	350,270,000	333,800,000	276,150,000	347,300,000	334,990,000	473,080,000

Management Performance

Year	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
ROIC	12.14%	13.37%	15.27%	14.78%	16.49%	21.10%	17.35%	14.64%	15.13%	13.97%	13.34%	9.91%	6.86%	8.67%
ROE	26.35%	34.86%	30.49%	11.79%	24.05%	27.28%	19.70%	16.11%	16.36%	15.40%	15.03%	10.99%	8.55%	10.07%
ROA	0.00%	13.62%	19.52%	7.01%	17.99%	26.23%	23.69%	18.99%	19.97%	18.31%	18.25%	13.49%	9.87%	8.68%
NM %	14.36%	19.71%	22.70%	9.20%	22.95%	25.92%	27.46%	23.22%	26.59%	29.28%	29.16%	22.61%	19.54%	21.38%
FCF / R%	0.00%	-64.16%	4.51%	21.43%	18.52%	30.05%	28.94%	27.07%	27.81%	20.44%	28.64%	17.79%	18.90%	15.09%
FCF / NI%	-125.55%	-230.96%	12.79%	161.58%	54.97%	74.40%	69.94%	75.57%	71.73%	50.37%	68.12%	55.02%	72.78%	70.56%
Operating Margin (OM)	0.00	0.42	0.53	0.62	0.82	0.87	1.04	1.12	1.29	1.49	1.59	1.72	1.85	1.73

Per Share

Year	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
EPS	1.61	3.26	4.68	1.81	4.68	6.97	8.19	8.07	9.95	11.58	13.06	10.70	9.45	11.92
SPS	11.20	16.52	20.60	19.71	20.41	26.89	29.82	34.75	37.42	39.54	44.80	47.32	48.35	55.75
OCPS	0.11	8.74	3.86	5.10	4.94	8.98	9.70	10.39	11.52	12.62	14.58	10.94	12.55	12.64
FCPS	-2.31	-10.60	0.93	4.22	3.78	8.08	8.63	9.41	10.41	8.08	12.83	8.42	9.14	8.41
BVPS	6.23	9.49	15.57	15.72	19.88	26.04	42.69	52.11	63.13	77.68	92.28	102.02	114.85	122.60

Per Share - CAGR

Year	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
CAGR-EPS	1.61	3.26	4.68	1.81	4.68	6.97	8.19	8.07	9.95	11.58	13.06	10.70	9.45	11.92
CAGR-SPS	11.20	16.52	20.60	19.71	20.41	26.89	29.82	34.75	37.42	39.54	44.80	47.32	48.35	55.75
CAGR-OCPS	0.11	8.74	3.86	5.10	4.94	8.98	9.70	10.39	11.52	12.62	14.58	10.94	12.55	12.64
CAGR-FCPS	-2.31	-10.60	0.93	4.22	3.78	8.08	8.63	9.41	10.41	8.08	12.83	8.42	9.14	8.41
CAGR-BVPS	6.23	9.49	15.57	15.72	19.88	26.04	42.69	52.11	63.13	77.68	92.28	102.02	114.85	122.60

Revenue $6.23B

+15.32%

10Y

Net Income $1.33B

+26.19%

10Y

Operating Cash Flow $1.41B

+0.72%

10Y

Free Cash Flow $940.56M

-7.95%

10Y

YTPD $0.17

+7.38%

10Y

D/E $0.04

+31.72%

10Y

CA/CL $7.61

-18.10%

10Y

TA/TL $9.34

-9.55%

10Y

ROIC $8.67%

+26.37%

10Y

ROE $10.07%

+17.70%

10Y

ROA $8.68%

-12.07%

10Y

Net Margin $21.38%

+9.42%

10Y

FCF / R% $15.09%

-20.18%

10Y

FCFNI % $70.56%

-3.06%

10Y

Operating Margin $1.73

-6.61%

10Y

EPS $11.92

+26.17%

10Y

SPS $55.75

+15.31%

10Y

OCPS $12.64

+0.70%

10Y

FCPS $8.41

-7.97%

10Y

BVPS $122.60

+6.75%

10Y

Wordpress Tutorials

eCommerce Website Tutorials

Responsive Design

Advanced

Stock Price

Fetching Data...

Fetching Data...

Fetching Data...

111,879,311

Market Cap of Advanced (ADVENZYMES.NS)

Market cap:

Year

Beginning Of Year

End Of Year

YOY Change

Revenue of Advanced (ADVENZYMES.NS)

Revenue:

Year

Revenue

YOY Change

Net Income of Advanced (ADVENZYMES.NS)

Net Income:

Year

Net Income

YOY Change

Free Cash Flow of Advanced (ADVENZYMES.NS)

Free Cash Flow:

Year

FreeCash flow

YOY Change

Operating Cash Flow of Advanced (ADVENZYMES.NS)

Operating Cash Flow:

Year

Operating Cashflow

YOY Change

Return on Invested capital of Advanced (ADVENZYMES.NS)

Return on Invested capital: %

%

Year

Return on Invested Capital

YOY Change

Return on Equity of Advanced (ADVENZYMES.NS)

Return on Equity: %

%

Year

Return on Equity

YOY Change

Return on Assets of Advanced (ADVENZYMES.NS)

Return on Assets: %

%

Year

ROA

YOY Change

Total debt of Advanced (ADVENZYMES.NS)

Total debt:

Year

MarketCap

YOY Change

Marketing Budget of Advanced (ADVENZYMES.NS)

Marketing Budget:

Year

MarketCap

YOY Change

Employee of Advanced (ADVENZYMES.NS)

Employee:

Year

Employees Number

YOY Change

Payroll of Advanced (ADVENZYMES.NS)

Payroll:

Year

Payroll

YOY Change

Dividends of Advanced (ADVENZYMES.NS)

Dividends:

Year

Dividends

YOY Change

Executive Compensation of Advanced (ADVENZYMES.NS)

Executive Compensation: